Science
Mechanism of Action
OCTACARBOXYMETHYL DIPEPTIDE-12 LYSINAMIDE is hypothesized to exert its effects primarily through the activation of Sirtuin 1 (SIRT1). This activation initiates cell-protective autophagy, a crucial process for cellular rejuvenation and resilience. Consequently, it is believed to offer anti-aging benefits, enhance the skin's natural antioxidant defense by upregulating antioxidant protein expression, and mitigate inflammation by reducing the secretion of pro-inflammatory mediators such as PGE-2 and various cytokines. Furthermore, its structural characteristics suggest it may contribute to skin barrier function and hydration as a Natural Moisturizing Factor (NMF) derivative.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Due to its strong ionic hydrophilic groups, this peptide, like similar structures, exhibits low stability when incorporated directly into cosmetic formulations and faces significant challenges in penetrating the skin's lipid barrier. To improve its efficacy and stability, advanced delivery systems such as encapsulation in nanovesicles, potentially utilizing polymeric gelling agents, polyhydric alcohols, phospholipids, ceramides, and glycolipids, are recommended.
Safety
Safety Profile
There are no official safety assessments from major regulatory bodies such as CIR, SCCS, or FDA specifically for Octacarboxymethyl Dipeptide-12 Lysinamide. The broader category of peptides can present immunogenicity concerns, and individual ingredient safety relies heavily on its specific purity and formulation context.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While its proposed mechanism suggests promising anti-aging and protective benefits, specific clinical data and comprehensive safety assessments for this peptide are currently lacking.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources